Abstract
Whilst diseases such as diabetes and cardiovascular disorders are increasing in the developed world, the main threat to global health remains viral-based infectious disease. Such diseases are notably prevalent in developing countries, where they represent a major cause of mortality; however, their detection and prevention is typically hampered by poor infrastructure and a lack of resources to support the sophisticated diagnostic tools commonly found in modern laboratories. Microfluidic-based diagnostics has the potential to close the gap between developed and developing world medical needs due to the robustness and reduced operating costs such technology offers. The most recent developments in microfluidic diagnostics for viral infections have explored the separation and enumeration of immune cells, the capture and identification of viral particles, and antiviral drug evaluation within microchannels and chambers. Advances in solid-phase separation, isothermal amplification, real-time detection of nucleotide products, and improved efficiency of detection systems in microfluidic platforms have also opened up opportunities for diagnostic innovation. This chapter reviews the potential capability microfluidic technology can offer in addressing the practical challenges of providing diagnostic technology for developing countries, illustrated by research on key viral diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Siefkes D (1993) The origin of HIV-1, the AIDS virus. Med Hypotheses 41(4):289–299
WHO (1978) Ebola haemorrhagic fever in Sudan, 1976. Bull World Health Organ 56(2):247–270
Ng CW, Choo WY, Chong HT, Dahlui M, Goh KJ, Tan CT (2009) Long-term socioeconomic impact of the Nipah Virus encephalitis outbreak in Bukit Pelanduk, Negeri Sembilan, Malaysia: A mixed methods approach. Neurology Asia 14(2):101–107
WHO (2009) Global Health Risks—Mortality and burden of disease attributable to selected major risks. Available from: http://www.who.int/healthinfo/global_burden_disease/global_health_risks/en/index.htmlAccessed 12 Nov 2012.
Welch RJA, Anderson BL, Litwin CM (2008) Evaluation of a new commercial enzyme immunoassay for the detection of IgM antibodies to West Nile virus using a ratio method to eliminate nonspecific reactivity. J Clin Lab Anal 22(5):362–266
Verweij PE, Erjavec Z, Sluiters W, Goessens W, Rozenberg-Arska M, Debets-Ossenkopp YJ et al (1998) Detection of antigen in sera of patients with invasive aspergillosis: Intra- and interlaboratory reproducibility. J Clin Microbiol 36(6):1612–1616
Cass T, Toumazou, C (2006) State of Science Review: Biosensors and Biomarkers. In: Foresight Infectious Diseases: Preparing for the Future: Office of Science and Innovation, London.http://www.bis.gov.uk/assets/foresight/docs/infectious-diseases/s7.pdf. Accessed 12 Nov 2012
Tian Y, Madanahally K, Rao H, Mackwan R, Chen L (2010) Sample-to-result nucleic acid test enables accurate detection of Influenza A/2009 H1N1 in 26 min in near-patient settings. Europ Infect Dis 4(4):26–30
Hauck TS, Giri S, Gao Y, Chan WCW (2010) Nanotechnology diagnostics for infectious diseases prevalent in developing countries. Adv Drug Deliv Rev 62(4–5):438–448
Yager P, Edwards T, Fu E, Helton K, Nelson K, Tam MR et al (2006) Microfluidic diagnostic technologies for global public health. Nature 442(7101):412–418
Moran MM, Guzman J, Henderson K, Abela-Oversteegan L, Wu L, Omune B, Gouglas, D, Chapman N, Zmundzki F (2011) Neglected disease research and development: Is the global financial crisis changing R&D? Global Funding of Innovation for Neglected Diseases.
Peeling RW, Holmes KK, Mabey D, Ronald A et al (2006) Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect 82(Supplement 5):v1–v6
Mengelle C, Kamar N, Mansuy JM, Sandres-Saune K, Legrand-Abeavanel F, Miedouge M, Rostaing L, Izopet J (2011) JC virus DNA in the peripheral blood of renal transplant patients: a 1-year prospective follow-up in France. J Med Virol 83(1):132–136
Liu C-J, Chen B-F, Chen P-J, Lai M-Y, Huang W-L, Horng K, Chen D-S (2006) Role of Hepatitis B Viral Load and Basal Core Promoter Mutation in Hepatocellular Carcinoma in Hepatitis B Carriers. J Infect Dis 193:1258–1265
Lai SK, Wang Y-Y, Wirtz D, Hanes J (2009) Micro- and macrorheology of mucus. Adv Drug Deliv Rev 61:86–100
Mairhofer J, Ropper K, Ertl P (2009) Microfluidic systems for pathogen sensing: a review. Sensors 9:4804–4823
Whitesides GM (2006) The origins and the future of microfluidics. Nature 442(7101):368–373
El-Ali J, Sorger PK, Jensen KF (2006) Cells on chips. Nature 442(7101):403–411
Pappas D, Wang K (2007) Cellular separations: A review of new challenges in analytical chemistry. Anal Chim Acta 601(1):26–35
Lu R, Shi W, Jiang L, Qin J, Lin B (2009) Rapid prototyping of paper-based microfluidics with wax for low-cost, portable bioassay. Electrophoresis 30(9):1497–1500
Osborn JL, Lutz B, Fu E, Kauffman P, Stevens DY, Yager P (2010) Microfluidics without pumps: Reinventing the T-sensor and H-filter in paper networks. Lab Chip 10(20):2659–2665
Namjilsuren T (2010) More developing countries show universal access to HIV/AIDS services is possible. World Health Organization [10 December 2010]; Available from: http://www.who.int/mediacentre/news/releases/2010/hiv_universal_access_20100928/en/index.html. Accessed 12 Nov 2012
Organization WH (1999) Operational characteristics of commerically available assays to determine antibodies to HIV-1 and/or HIV-2 in human sera. World Health Organization
Feardon M (2005) The laboratory diagnosis of HIV infections. Can J Infect Dis Med Microbiol 16(1):26–30
Cheng X, Gupta A, Chen C, Tompkins RG, Rodriguez W, Toner M (2009) Enchancing the performance of a point-of-care CD4+ T-cell counting microchip through monocyte depletion for HIV/AODS diagnostics. Lab Chip 9:1357–1364
Wang J-H, Wang C-H, Lin C-C, Lei H-Y, Lee G-B (2010) An integrated microfluidic system for counting of CD4+/CD8+ T lymphocytes. Microfluidics and Nanofluidics.
Chen GD, Alberts CJ, Rodriguez W, Toner M (2010) Concentration and Purification of Human Immunodeficiency Virus Type 1 Virions by Microfluidic Separation of Superparamagnetic Nanoparticles. Anal Chem 82(2):723–728
Lee SH, Kim S-W, Kang J-Y, Ahn CH (2008) A polymer lab-on-a-chip for reverse transciption (RT)-PCR based point-of-care clinical diagnostics. Lab Chip 8:2121–2127
Qiu X, Thompson JA, Chen Z, Liu C, Chen D, Ramprasad S, Mauk MG, Ongagna S, Barber C, Abrams WR, Malamud D, Corstjens PLAM, Bau HH (2009) Finger-actuated, self-contained immunoassay cassettes. Biomed Microdevices 11:1175–1186
Public health research agenda for influenza A(H1N1) (2009) pandemic, World Health Organisation Technical Consultation Report, 2011, Tunisia, World Health Organisation http://whqlibdoc.who.int/hq/2011/WHO_HSE_GIP_ITP_2011.3_eng.pdf [Accessed 12 Nov 2012].
Kao LT-H, Shankar L, Kang TG, Zhang G, Tay GKI, Rafei SRM, Lee CWH (2011) Multiplexed detection and diffferentiation of the DNA strains for influenza A (H1N1 2009) using silicon-based microfluidic system. Biosens Bioelectron 26(5):2006–2011
Bhattacharyya A, Klapperich CM (2008) Microfluidics-based extraction of viral RNA from infected mammalian cells for disposable molecular diagnostics. Sensors Actuators B-Chemical 129:693–698
Reichmuth DS, Wang SK, Barrett LM, Throckmorton DJ, Einfeld W, Singh AK (2008) Rapid microchip-based electrophoretic immunoassays for the detection of swine influenza virus. Lab Chip 8:1319–1324
Dengue and dengue haemorrhagic fever (2009) World Health Organization [December 2010]; Available from: http://www.who.int/mediacentre/factsheets/fs117/en/index.htmlAccessed 12 Nov 2012.
Lien K-Y, Lee W-C, Lei H-Y, Lee G-B (2007) Integrated reverse transcription polymerase chain reaction systems for virus detection. Biosens Bioelectron 22:1739–1748
Li C, Dong X, Qin J, Lin B (2009) Rapid nanoliter DNA hybridization based on reciprocating flow on a compact disk microfluidic device. Anal Chim Acta 640:93–99
Marco A, Marin I (2009) CGIN1: A retroviral contribution to mammalian genomes. Mol Biol Evol 26(10):2167–2170
Horie M, Honda T, Suzuki Y, Kobayashi Y, Daito T, Oshida T et al (2010) Endogenous non-retroviral RNA virus elements in mammalian genomes. Nature 463(7277):84–87
Gulliksen A, Solli LA, Drese KS, Sorensen O, Karlsen F, Rogne H, Hovig E, Sirevag R (2005) Parallel nanoliter detection of cancer markers using polymer microchips. Lab Chip 5:416–420
Manage DP, Morrissey, Y.C., Stickel, A.J., Lauzon, J., Atrazhev, A., Acker, J.P., Pilarski, L.M. (2011) On-chip PCR amplification of genomic and viral templates in unprocessed whole blood Microfluidics and Nanofluidics 10(3):697–702
Gardner SD, Field AM, Coleman DV, Hulme B (1971) New human papovavirus (BK) isolated from urine after renal transplantation. Lancet 7712:1253–1257
Zhu Y, Warrick JW, Haubert K, Beebe DJ, Yin J (2009) Infection on a chip: a microscle platform for simple and sensitive cell-based virus assays. Biomed Microdevices 11:565–570
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media,LLC
About this protocol
Cite this protocol
Hattersley, S.M., Greenman, J., Haswell, S.J. (2013). The Application of Microfluidic Devices for Viral Diagnosis in Developing Countries. In: Jenkins, G., Mansfield, C. (eds) Microfluidic Diagnostics. Methods in Molecular Biology, vol 949. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-134-9_19
Download citation
DOI: https://doi.org/10.1007/978-1-62703-134-9_19
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-133-2
Online ISBN: 978-1-62703-134-9
eBook Packages: Springer Protocols